Andrew Becker

This inventor holds 2 USPTO granted patents. Top assignees: Neurocrine Biosciences, Inc., Sanofi. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew Becker. Retrieved from https://idiyas.com/inventor/andrew-becker-21exkmdh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)

Company Filing History:

2 out of 123

Neurocrine Biosciences, Inc.

where one patent can have more than one assignee

Years Active: 2024-2026

Loading Chart...

2 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12582634 - Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine (2026-03-24),

2. 12128033 - Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-n-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-n-prop-2-ynyl-1,3-thiazol-2-amine (2024-10-29),

Title: The Innovative Contributions of Andrew Becker

Introduction

Andrew Becker is a notable inventor based in San Diego, CA. He has made significant contributions to the fields of chemistry and medicine. With a total of 2 patents, his work focuses on innovative synthetic methods that have potential applications in treating medical conditions.

Latest Patents

Becker's latest patents include synthetic methods for the preparation of 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1S)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-prop-2-ynyl-1,3-thiazol-2-amine. This compound is particularly relevant for the treatment of congenital adrenal hyperplasia (CAH). The processes he developed aim to create pharmaceutically acceptable salts and crystalline forms of this compound, showcasing his expertise in medicinal chemistry.

Career Highlights

Throughout his career, Andrew Becker has worked with prominent companies such as Sanofi and Neurocrine Biosciences, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in his field.

Collaborations

Becker has collaborated with notable colleagues, including Joel Radisson and Scott Stirn. These partnerships have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

Andrew Becker's contributions to the fields of chemistry and medicine through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]